The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included
about 800 older men with low testosterone and symptoms associated with this affliction, including anti aging supplements
for men (tinyurl.com
) sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
Studies have shown that testosterone deficiency is associated with a number of critical health problems for example obesity, diabetes, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should receive therapy. In reality, your testosterone levels have likely been slowly declining for some time, a decline that generally starts around age 30.
And many girls have a knee jerk suspicion that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes this will likely remain the status quo for a little while, given the prohibitive cost of conducting the long term safety studies needed to win FDA acceptance that is fuller.